Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
+5.1M
-
Total reported value, excl. options
-
$198M
-
Value change
-
+$32M
-
Put/Call ratio
-
0.09
-
Number of buys
-
72
-
Number of sells
-
-29
-
Price
-
$5.68
Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q2 2025
120 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q2 2025.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 51.9M outstanding shares and own 67.25% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (4.37M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.07M shares), BlackRock, Inc. (3M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.68M shares), VANGUARD GROUP INC (2.51M shares), Western Standard LLC (2.09M shares), Vivo Capital, LLC (1.84M shares), BOONE CAPITAL MANAGEMENT LLC (1.25M shares), GEODE CAPITAL MANAGEMENT, LLC (1.11M shares), and Propel Bio Management, LLC (974K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.